Sep 25, 2025 6:45 AM Eastern Daylight Time Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 Share More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines and potential of next-generation pipeline NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) will highlight data across its extensive Oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, being held Oc ...

16 abstracts, including two oral presentations, feature new clinical data from Astellas' oncology portfolio TOKYO, May 19, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (May 30 - June 3). The research underscores Astellas' dedication as a pioneer in oncology and focus on clinical outcomes that matter to ...